Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.12−0.05 (-2.30%)
Close on Nov 20, 2026Market cap $270.03MP/E –Yield –
Nautilus Biotechnology operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | -$1.78M | – |
| Q3 FY2020 | Sep 30, 2020 | -$174.67K | – |
See a number that looks wrong?